Repertoire Immune Medicines

1 Follower

About

Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.

Anthony Coyle
President, Research and Development
Sok Cheng Soh
Chief Financial Officer
Jan Kisielow
Chief Scientific Officer, Repertoire Immune Medicines (Switzerland) Ltd.
Lucia Celona
EVP, Chief Human Resources Officer
Andrea DiFabio
EVP, Chief Legal and Administration Officer
Tim Harris
EVP, Corporate Development
Franz-Josef Obermair
General Manager, Tepthera Subsidiary
Daniel Pregibon
Head of Platform Discovery and Technology

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.